CStone Reports CS2009 Clinical Data From More Than 300 Patients
CStone said data presented at ESMO 2026 support CS2009’s mechanism, safety and broad antitumor activity.
CStone said data presented at ESMO 2026 support CS2009’s mechanism, safety and broad antitumor activity.